Most people around the world already know that ADHD is one of the most common neurodevelopmental disorders among people aged eighteen and under but what is the right way to go about treating it? Well, back in 1976, J.F. Lubar became one of the first scientists to study the effects of neurofeedback on patients with ADHD and the results were nothing short of astounding. Over thirty years later, scientists are combining his research with modern technology to find the most effective methods of treating ADHD. Learn more about Neurocore at Crunchbase. Neurocore is also building on his research and having much luck in the treatment process as their methods evolve. In fact, over four-fifths of the patients they’ve treated for ADHD have noted a significant decrease in the number of symptoms they experienced and over half of them no longer met the requirements to be considered a patient with ADHD. They found that most cases of the disorder are often a direct result of sleep deprivation, anxiety, learning disabilities, and many other conditions. Read more about Neurocore at glassdoor.com. That is precisely why Neurocore remains committed to finding the most effective method of treatment for ADHD and someday they even hope to discover a cure for it. Using something known as Qeeg technology, they’ve already been able to deduce that ADHD consists of an increase in theta waves and a decrease in beta waves. Researchers have often categorized ADHD into three separate categories which vary according to the various symptoms the patient exhibits. These three subcategories are predominantly inattentive presentation, predominately hyperactive-impulsive presentation and the third subcategory is just an amalgamation of the first two. In recent years, they’ve done studies about the disorder that have concluded that ADHD tends to be a hereditary condition passed down from one generation to the next. Since its inception almost fifteen years ago, Neurocore has focused on providing neurological assessments to help people focus in school and at work and become better employees and students. So we wish them the best of luck in their efforts to find a cure for this disorder and hope they have success in their treatments of patients with ADHD.
— Neurocore (@neurocore) September 11, 2018